Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 1, 2010, Pages 46-50

  Zelinkova, Zuzana ^a   Mensink, Peter Bf ^a   Dees, Jan ^a   Kuipers, Ernst J ^a   Van Der Woude, Christien J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Conception; Inflammatory bowel diseases; Medication

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT DEPARTMENT; PREGNANCY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; FEMALE; FERTILIZATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 73649113101     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903362628     Document Type: Article

References (15)

1. Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: A mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009;15:720-725
2. Zelinkova Z, Baars J, Marcus T, Kuipers EJ, van der Woude CJ. Female perception of the quality of life differs from male inflammatory bowel disease patients. Gut 2007;39 (Suppl I):A145.
3. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987-994
4. Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:591-599
5. Heetun ZS, Byrnes C, Neary P, O'Morain C. Review article: Reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther 2007;26:513-533
6. Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, et al. The safety of mesalamine in human pregnancy: A prospective controlled cohort study. Gastroenterology 1998;114:23-28
7. Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006;55(Suppl 1):i36-58.
8. Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology 1994;49:79-81.
9. Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 2004;99:656-661
10. Marteau P, Tennenbaum R, Elefant E, Lémann M, Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 1998;12:1101-1108
11. O'Donnell S, O'Morain C. Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception. Aliment Pharmacol Ther 2008;27:885-894
12. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006;4:1255-1258
13. Mahadevan U, Terdiman JP, Church J, Vasiliauskas E, Gitis A, Dubinsky MC. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterology 2007;132(Suppl 2):A144.
14. Oussalah A, Roblin X, Laharie D, Filippi J, Flamant M, Faure P, et al. Tumour necrosis factor antagonists and inflammatory bowel diseases: A national practice survey. Aliment Pharmacol Ther 2009 Jul 14;Epub ahead of print.
15. Zankel E, Rogler G, Andus T, Reng CM, Schölmerich J, Timmer A, et al. Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohort. Eur J Gastroenterol Hepatol 2005;17:395-401.